Autologous Stem Cell Transplantation in elderly Acute Myeloid Leukemia

Treatment outcome in elderly Acute Myeloid Leukemia (AML) is still very disappointing. Although complete remission rate is around 50–60% the 2 years survival is only in the magnitude of 10–20%. This is mainly due to an overrepresentation of adverse prognostic factors present in elderly AML. As relap...

Descripción completa

Detalles Bibliográficos
Autores principales: Ossenkoppele, Gert J, Janssen, Jeroen JWM, Huijgens, Peter C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591258/
https://www.ncbi.nlm.nih.gov/pubmed/23505606
http://dx.doi.org/10.4084/MJHID.2013.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591258/
https://www.ncbi.nlm.nih.gov/pubmed/23505606
http://dx.doi.org/10.4084/MJHID.2013.018

Ejemplares similares